NO20081040L - Reduced HSMI mortality - Google Patents

Reduced HSMI mortality

Info

Publication number
NO20081040L
NO20081040L NO20081040A NO20081040A NO20081040L NO 20081040 L NO20081040 L NO 20081040L NO 20081040 A NO20081040 A NO 20081040A NO 20081040 A NO20081040 A NO 20081040A NO 20081040 L NO20081040 L NO 20081040L
Authority
NO
Norway
Prior art keywords
hsmi
mortality
reduced
nutritional
cardiac
Prior art date
Application number
NO20081040A
Other languages
English (en)
Inventor
Kjell-Arne Rorvik
Rolf Kristian Berge
Henriette Alne
Magny Thomassen
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Priority to NO20081040A priority Critical patent/NO20081040L/no
Priority to PCT/NO2009/000069 priority patent/WO2009108067A2/en
Priority to CL2009000460A priority patent/CL2009000460A1/es
Priority to EP09714090A priority patent/EP2257282A2/en
Publication of NO20081040L publication Critical patent/NO20081040L/no
Priority to NO20101223A priority patent/NO20101223L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

Det beskrives anvendelse av en forbindelse for fremstilling av en ernæringsmessig og/eller farmasøytisk sammensetning for å redusere mortaliteten relatert til hjerte- og skjelettmuskelinflammasjon (HSMI) i fisk.
NO20081040A 2008-02-27 2008-02-27 Reduced HSMI mortality NO20081040L (no)

Priority Applications (5)

Application Number Priority Date Filing Date Title
NO20081040A NO20081040L (no) 2008-02-27 2008-02-27 Reduced HSMI mortality
PCT/NO2009/000069 WO2009108067A2 (en) 2008-02-27 2009-02-27 Prevention and treatment of hsmi
CL2009000460A CL2009000460A1 (es) 2008-02-27 2009-02-27 Uso de un carboxilato con atomos de azufre, selenio, grupo so o so2 para preparar composiciones para prevenir o tratar la inflamacion del musculo esqueletico y cardiaco (hsmi) de los peces, y/o para reducir la mortalidad de los peces con hsmi o que son suseptibles a hsmi; alimento para peces que comprende dicho compuesto.
EP09714090A EP2257282A2 (en) 2008-02-27 2009-02-27 Fatty acid derivatives for use in the prevention and treatment of hsmi
NO20101223A NO20101223L (no) 2008-02-27 2010-09-02 Prevention and treatment of HSMI

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20081040A NO20081040L (no) 2008-02-27 2008-02-27 Reduced HSMI mortality

Publications (1)

Publication Number Publication Date
NO20081040L true NO20081040L (no) 2009-08-28

Family

ID=41003478

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20081040A NO20081040L (no) 2008-02-27 2008-02-27 Reduced HSMI mortality
NO20101223A NO20101223L (no) 2008-02-27 2010-09-02 Prevention and treatment of HSMI

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20101223A NO20101223L (no) 2008-02-27 2010-09-02 Prevention and treatment of HSMI

Country Status (4)

Country Link
EP (1) EP2257282A2 (no)
CL (1) CL2009000460A1 (no)
NO (2) NO20081040L (no)
WO (1) WO2009108067A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO341929B1 (no) * 2009-09-14 2018-02-19 Chemoforma Ltd Fôrsammensetning
NO347765B1 (no) * 2012-11-01 2024-03-18 Ewos Innovation As Fôrsammensetning for fisk

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2429711B (en) * 2004-06-11 2008-05-21 Pharmaq As Heart and skeletal muscle inflammation (HSMI) virus
EP2275140B1 (en) * 2004-07-19 2017-11-01 Bergen Teknologioverforing AS Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
NO20055541L (no) * 2005-11-23 2007-05-24 Berge Biomed As Use of fatty acid analogues

Also Published As

Publication number Publication date
WO2009108067A3 (en) 2009-11-12
EP2257282A2 (en) 2010-12-08
CL2009000460A1 (es) 2010-02-05
WO2009108067A2 (en) 2009-09-03
NO20101223L (no) 2010-09-02

Similar Documents

Publication Publication Date Title
CU20140141A7 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas
ECSP13012668A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
PA8794401A1 (es) Acidos 6-fenilnicotinicos sustituidos y su uso
BR112012031183A2 (pt) líquidos nutricionais substancialmente claros compreendendo proteína de cálcio hmb e solúvel
UY31228A1 (es) Ariloxazoles sustituidos y su uso
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
GB2462221B (en) Administration of relaxin to reduce diuretic use in humans with acute decompensated heart failure
CO6640311A2 (es) Compuestos, composiciones de tioacetato y métodos de uso
BRPI0920670A2 (pt) composição nutritiva para promover o desenvolvimento e crescimento sadios
UA107445C2 (uk) 5-фторпіримідинові похідні як фунгіциди
SV2011003901A (es) Compuestos de arilo con sustituyentes heterocíclicos como inhibidores de hif
DK3153526T3 (da) Antistoffer mod human cd39 og anvendelse deraf til inhibering af aktivitet af t-regulatoriske celler
ECSP11011082A (es) Compuestos, composición farmaceutica y métodos para utilizarse en el tratamiento de desórdenes metabólicos
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
CL2012000096A1 (es) Uso de alfa-pineno y cinamaldehido en composicion de alimentos que sirve para mejorar tasa de convension en animales acuaticos; composicion de alimentos; y aditivo que contienen alfa-pineno y cinamaldehido como ingredientes principales.
HN2011003341A (es) Producto de proteina y procedimiento para preparar un producto de proteina inyectable
NO20081040L (no) Reduced HSMI mortality
UY30582A1 (es) Derivados de acido 2-fenoxinicotinico y su uso
WO2011031166A3 (en) Fish feed
AR086437A1 (es) Preparado de huevo con propiedades regeneradoras, analgesicas y/o anti-inflamatorias
CL2008002828A1 (es) Tableta oral que comprende una cantidad mayor de 38% de alisquireno o una de sus sales y fosfato acido de calcio como relleno.
NO20075894L (no) Redusert kjonnsmodning i fisk
CN105029538A (zh) 一种芹菜瘦身汤
AR081024A1 (es) Asociacion de los inhibidores de la xantina oxidasa y la metformina y su uso
CL2008000864A1 (es) Compuestos derivados de pirimidina; composicion farmaceutica que comprende a dichos compuestos; procedimiento de preparacion de la composicion farmaceutica; y su uso para enfermedades relacionadas con el factor de crecimiento analogo a la insulina (igf).

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application